Sedatives & Hypnotics

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/54

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 7:26 PM on 10/8/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

55 Terms

1
New cards

What clinical uses are listed for sedative-hypnotics?

Anxiety, insomnia, seizures, procedural sedation/amnesia, muscle relaxation, and control of alcohol or other sedative withdrawal.

2
New cards

How does sleep-onset insomnia differ from sleep-maintenance insomnia?

Sleep onset: difficulty falling asleep. Sleep maintenance: difficulty staying asleep.

3
New cards

How do pharmacokinetics influence hypnotic selection?

Rapid onset helps sleep initiation; longer duration helps sleep maintenance but can increase next-day hangover effects.

4
New cards

What is the benzodiazepine mechanism of action?

Potentiate GABA at GABA-A receptors and increase the frequency of chloride-channel opening.

5
New cards

How does increased chloride entry produce benzodiazepine effects?

It increases neuronal inhibition, reducing neuronal activity.

6
New cards

Which benzodiazepines are highlighted for insomnia versus conscious sedation?

Insomnia: flurazepam, temazepam, triazolam. Conscious sedation: midazolam.

7
New cards

Which benzodiazepines are commonly used for anxiety in the lecture?

Alprazolam, clonazepam, and lorazepam.

8
New cards

Which benzodiazepines are listed for alcohol withdrawal?

Chlordiazepoxide and diazepam.

9
New cards

What distinguishes midazolam's kinetics and uses?

Rapid onset and short duration; used for procedural sedation and seizures/status epilepticus. IV onset is faster than oral onset.

10
New cards

What distinguishes triazolam from temazepam?

Triazolam: rapid onset and short duration. Temazepam: slower oral absorption/onset; listed for both sleep onset and maintenance.

11
New cards

Why can flurazepam cause prolonged or next-day effects?

Long-lived active metabolites extend its duration.

12
New cards

What important pharmacokinetic concerns are listed for diazepam and chlordiazepoxide?

Active metabolites can prolong effects; IM absorption is erratic.

13
New cards

Which benzodiazepine has no active metabolites and is highlighted as safer in older adults if one is needed?

Lorazepam; benzodiazepines still require caution in older adults.

14
New cards

What are the major benzodiazepine adverse effects?

Sedation, dizziness, cognitive impairment, confusion, hangover effects, hypotension, and increased fall risk.

15
New cards

How do benzodiazepines affect sleep architecture?

Increase total sleep time but reduce time in REM sleep.

16
New cards

What is the recommended place of benzodiazepines in insomnia therapy?

As-needed short-term relief; long-term maintenance is not ideal because they are habit-forming and difficult to discontinue.

17
New cards

What abuse-related precautions apply to benzodiazepines?

Schedule IV controlled substances with abuse/misuse potential; use cautiously in patients with substance-use histories.

18
New cards

Why are benzodiazepines concerning in older adults?

Increased falls and cognitive impairment; slower clearance can prolong effects. They are on the Beers list.

19
New cards

What monitoring is emphasized for benzodiazepines?

Sedation/consciousness, sleep-pattern changes, and respiratory rate in hospitalized patients.

20
New cards

What symptoms suggest benzodiazepine withdrawal?

Anxiety/panic, rebound insomnia, tremor, sweating, palpitations, nausea/vomiting, headache, and altered perception; severe cases include hallucinations, psychosis, and seizures.

21
New cards

What patterns increase benzodiazepine withdrawal risk?

Higher doses, short-acting agents, and use longer than 4 weeks.

22
New cards

How does the barbiturate mechanism differ from benzodiazepines?

Barbiturates increase the duration of chloride-channel opening and can directly activate the channel; benzodiazepines increase opening frequency.

23
New cards

Do barbiturates and benzodiazepines bind at the same site?

No; they act at different binding sites.

24
New cards

Which barbiturates appear in the slides and chart?

Phenobarbital, pentobarbital, thiopental, and secobarbital.

25
New cards

Why are barbiturates no longer used routinely for insomnia?

Less predictable kinetics and extended half-lives can produce undesirable cumulative effects.

26
New cards

What are phenobarbital's major uses in the lecture?

Alcohol withdrawal, long-term epilepsy treatment, and acute status epilepticus management.

27
New cards

What are pentobarbital and thiopental used for in the lecture?

Sedation, refractory seizures/status epilepticus, and barbiturate-induced coma; lethal injection/euthanasia is also listed.

28
New cards

What are the major barbiturate adverse effects?

Sedation, dizziness, confusion, cognitive impairment, hangover effects, falls, hypotension, and bradycardia.

29
New cards

Which barbiturate cardiovascular effects are more common with IV administration?

Hypotension and bradycardia.

30
New cards

What monitoring is emphasized for barbiturates?

Sleep latency, daytime sedation, cognition, and inpatient respiratory rate; phenobarbital may require therapeutic drug monitoring.

31
New cards

What is the mechanism of Z-drugs?

Potentiate GABA and increase chloride-channel opening frequency at the benzodiazepine binding site, despite being structurally unrelated to benzodiazepines.

32
New cards

Which medications are Z-drugs?

Zolpidem (Ambien), zaleplon (Sonata), and eszopiclone (Lunesta).

33
New cards

Which Z-drug is useful for sleep onset but not sleep maintenance, and why?

Zaleplon; its short duration makes it ineffective for maintaining sleep.

34
New cards

Which Z-drug is useful for both sleep onset and maintenance?

Eszopiclone; its longer duration also makes next-day hangover effects more likely than with shorter-acting options.

35
New cards

What formulation and pharmacokinetic features distinguish zolpidem?

No active metabolites; sublingual formulation for patients unable to swallow tablets and controlled-release formulation for longer duration.

36
New cards

What are the major Z-drug adverse effects?

Sedation, dizziness, amnesia, confusion, cognitive impairment, falls, and hangover effects, especially with extended-release formulations.

37
New cards

What distinctive safety problem is associated with Z-drugs?

Complex sleep behaviors, including sleepwalking, sleep-driving, and sleep-eating.

38
New cards

What is the recommended place of Z-drugs in insomnia treatment?

As-needed short-term relief; the lecture advises against nightly or long-term maintenance use because they are habit-forming.

39
New cards

What abuse and older-adult concerns apply to Z-drugs?

Schedule IV with abuse/misuse potential; Beers-list concerns include falls and cognitive impairment, with prolonged effects from slower clearance.

40
New cards

What is the mechanism of dual orexin receptor antagonists?

Block orexin A/B signaling, preventing its wake-promoting effects.

41
New cards

Which medications are DORAs, and what insomnia patterns can they treat?

Daridorexant, suvorexant, and lemborexant; used for sleep onset and sleep maintenance.

42
New cards

What adverse effects and dose-related pattern are listed for DORAs?

Dizziness, fatigue, headache, next-day somnolence, and possible abnormal dreams; adverse effects increase at higher doses.

43
New cards

How do CYP3A4 inhibitors affect DORAs, and which examples are listed?

Increase drug concentrations and adverse effects. Examples: amiodarone, grapefruit juice, fluconazole, diltiazem, and verapamil.

44
New cards

How do CYP3A4 inducers affect DORAs, and which examples are listed?

Decrease drug concentrations and effectiveness. Examples: carbamazepine, rifampin, phenytoin, and St. John's wort.

45
New cards

What is the mechanism of melatonin receptor agonists?

Stimulate MT1 and MT2 receptors; MT1 induces sleepiness and MT2 influences circadian rhythm.

46
New cards

How do ramelteon and tasimelteon differ in indication?

Ramelteon: sleep-onset insomnia. Tasimelteon: non-24-hour sleep-wake disorder.

47
New cards

Why may melatonin receptor agonists be useful when avoiding habit-forming medications?

They are noncontrolled and useful for patients with substance-use disorders; the lecture describes them as an option when long-term medication is needed.

48
New cards

What adverse effects and sleep-architecture advantages are listed for melatonin receptor agonists?

Dizziness, fatigue, headache, and possible abnormal dreams; they do not appear to alter sleep architecture or interfere with REM sleep.

49
New cards

How do CYP1A2 inhibitors and inducers affect melatonin receptor agonists?

Inhibitors increase concentrations/adverse effects: fluvoxamine, ciprofloxacin, verapamil. Inducers reduce effectiveness: cigarette smoke, carbamazepine, rifampin, omeprazole.

50
New cards

Which sedating antidepressants are covered, and what receptor effect contributes to sedation?

Amitriptyline, doxepin, mirtazapine, and trazodone; histamine H1 antagonism contributes to drowsiness.

51
New cards

What distinguishes doxepin from the other sedating antidepressants in this lecture?

Doxepin is FDA-approved for sleep-maintenance insomnia; the other listed antidepressant uses for insomnia are generally off-label.

52
New cards

When may sedating antidepressants be useful, and what risks are emphasized?

Insomnia with concomitant depression; noncontrolled, but can cause next-day sedation, dizziness, and increased falls in older adults.

53
New cards

Which medications should be used for sleep latency/onset for insomnia?

Eszopiclone, ramelteon, temazepam, triazolam, zaleplon, and zolpidem.

54
New cards

Which medications should be used for sleep maintenance for insomnia?

Doxepin, eszopiclone, temazepam, suvorexant, and zolpidem.

55
New cards

Which medications are not recommended for insomnia?

Diphenhydramine, melatonin, tiagabine, trazodone, L-tryptophan, and valerian; trazodone is discussed as an off-label option but is not recommended in this table.